empagliflozin
Empagliflozin is a sodium glucose co-transporter-2 inhibitor indicated as an adjunct to diet and exercise to improve glycemic control in adult patients with type 2 diabetes.. Reference standards of Empagliflozin API, and its pharmacopeial, non pharmacopeial impurities, and stable isotopes are listed below
stdClass Object
(
[pname] => (3R)-Tetrahydro-3-furanyl-4-methylbenzenesulphonate
[catalogue_number] => PA 05 56530
[category_ids] => ,69,100,78,70,82,
[chemical_name] =>
[weight] => 242.29
[form] => C11H14O4S
[cas] => 219823-47-9
[pslug] => 219823-47-9-3r-tetrahydro-3-furanyl-4-methylbenzenesulphonate-pa0556530
[latest_product] => 0
[linkproducts] => 0
[offers_id] =>
[offers_name] =>
[offers_status] =>
[offers_start_date] =>
[offers_end_date] =>
[pageview] =>
[offers_slug] =>
[offers_product_id] =>
[offers_product_code] =>
[offers_master_id] =>
[offer_percentage] =>
[offers_product_main_cat] =>
)
(3R)-Tetrahydro-3-furanyl-4-methylbenzenesulphonate
Catalogue No.:PA 05 56530
Molecular Formula : C11H14O4S
Molecular Weight : 242.29